Strong Fourth Quarter Fueled by Market Share Expansion and Operating Leverage Annual GMV Surpasses $1.5 Billion Milestone with Record Number of Auction Participants BETHESDA, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), the leading global provider of e-commerce marketplaces and software solutions powering the circular economy, today announced its financial results for its fiscal quarter and year ended September 30, 2025: Fourth Quarter Results:Gross Merchandise Volume (GMV) of $404.5 million, up 12%, and Revenue of $118.1 million, up 10% GAAP Net Income of $7.8 million, up 23%, and GAAP Diluted Earnings Per Share (EPS) of $0.24, up 20% Non-GAAP Adjusted EBITDA of $18.5 million, up 28%, and Non-GAAP Adjusted EPS of $0.37, up 16% Cash balances of $185.8 million1 with zero financial...

(all amounts are expressed in millions of U.S. dollars, excluding per share amounts and unless otherwise stated) TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) —  Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the fourth quarter and fiscal year ended September 30, 2025. “Our business demonstrated resilience and competitive strength throughout 2025 as we consistently launched new clients, expanded market share, and maintained strong financial discipline. We launched 10 new clients and one new channel in U.S. Appraisal and Canada, and both these segments continued to generate solid positive Adjusted EBITDA(A). We expanded our U.S. Title business by adding seven new clients, including a second...

BEIJING, Nov. 20, 2025 (GLOBE NEWSWIRE) — Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial and Operational SnapshotsNet revenues were RMB523.0 million (US$73.5 million), compared to RMB491.3 million in the third quarter of 2024. Gross billings (non-GAAP) were RMB349.2 million (US$49.0 million), compared to RMB360.3 million in the third quarter of 2024. Gross profit was RMB462.7 million (US$65.0 million), compared to RMB409.2 million in the third quarter of 2024. Net income was RMB125.4 million (US$17.6 million), compared to RMB89.3 million in the third quarter of 2024. Net income margin1...

Luxembourg – 20 November 2025 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, ISIN: LU0075646355, the Company) announced today results of Subsea7 Group (the Group, Subsea7) for the third quarter which ended 30 September 2025. Highlights Third quarter Adjusted EBITDA of $407 million, up 27% on the prior year period, equating to a margin of 22% Solid operational and financial performance from both Subsea and Conventional and Renewables, with Adjusted EBITDA margins of 24% and 17%, respectively Full year 2025 revenue is expected to be in a range between $6.9 and 7.1 billion while margins are expected to be between 20 and 21% Record high, quality backlog of $13.9 billion including $6.0 billion for execution in 2026 and $3.8 billion in 2027 Based on our firm backlog of contracts for execution in 2026, we expect revenue within a range of $7.0...

GUANGZHOU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2025. Recent Business UpdatesTherapy SelectionPresented study results at the Cell Reports Medicine on esophageal squamous cell carcinoma in September 2025. “Integrating ctDNA with clinical response evaluation improves residual disease detection post-neoadjuvant chemoradiotherapy to support organsparing strategies and that postoperative ctDNA stratifies recurrence risk beyond pathological response to inform adjuvant immunotherapy decisions”.Early DetectionPROMISE study test results presented at The Innovation...

Nilfisk CEO, Jon Sintorn, comments on Q3 2025 results: “In the third quarter of 2025, we continued to improve our cost structure and competitiveness to build resilience despite ongoing macroeconomic uncertainty. I was pleased to see growth in our Professional Business across all regions. Positively, EMEA delivered organic growth for the seventh consecutive quarter, and APAC achieved organic growth for the third consecutive quarter. Americas also grew in the quarter over a weak quarter same period last year. External headwinds, including tariffs and softer end-user demand, affected our margin. However, we maintained steady operational performance, reduced our cost, and improved free cash flow. A number of structural changes and decisions were executed in the quarter to improve our profitability and competitiveness. These changes and decisions...

Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, will hold its Capital Markets Day for analysts and investors via live webcast and in-person in Gorinchem, the Netherlands today. Corbion management will present its strategy for the period 2026-2030: BRIGHT 2030, a new strategy designed to lead the way in sustainable specialty food ingredients for preservation and nutrition. BRIGHT 2030: Key strategic prioritiesAccelerate clean-label preservation and formulation in food, responding to increasing consumer demand for transparency and natural solutionsExpand algal fermentation beyond omega-3 oils, unlocking new opportunities in pet food and human nutrition Foster growth in Biomedical Polymers, reinforcing Corbion’s presence in high-value healthcare applicationsStrategic...

Louvain-la-Neuve, Belgium, 20 November 2025 – IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, shares its business update for the third quarter of 2025. Group OverviewEquipment order intake at €195 million as of Q3 2025 (+6% vs. last year) with a strong contribution from IBA Technologies (+22%) driven by RadioPharma Solutions, and four Proteus®ONE solutions sold within IBA Clinical.   Equipment and Services backlog stable at €1.3 billion, with sustained backlog conversion. FY2025 REBIT guidance confirmed: at least €25 million, supported by well under control OpEx and an already positive REBIT contribution from Proton Therapy. At net result level, financials continue to be impacted by foreign exchange fluctuations (primarily USD and CNY). Net debt position at €60 million1 as of September 30,...

Total revenues of €127.0 million compared to €116.6 million in the first nine months of 2024 Cash and cash equivalents of €143.5 million at end of September 2025 Financial flexibility enhanced with successful debt refinancing in October 20251 Lyme disease Phase 3 study VALOR on track Updated 2025 financial outlook confirmed1Saint-Herblain (France), November 20, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported consolidated financial results for the first nine months of the year, ended September 30, 2025. The condensed consolidated interim financial results are available on the Company’s website (Financial Reports – Valneva). Valneva will provide a live webcast of its nine-month 2025 results conference call beginning at 3 p.m. CET / 9 a.m. ET today. This webcast will also be available...

TORBAL DIVISION SALES UP 15% YTDLAUNCH OF VIVID’S FIRST AI-POWERED FEATURESECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26 Investor Call to be held Thursday, November 20th at 11:00 a.m. Eastern Time BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) — Scientific Industries, Inc. (OTCQB: SCND), a leading developer of digitally simplified bioprocessing solutions and vision-based pill counters, today reported financial results for the three and nine months ended September 30, 2025, and announced the launch of a new AI-enabled feature for its VIVID WORKSTATION. Business Highlights:Launched an innovative prescription label documentation and verification feature for the VIVID WORKSTATION, harnessing AI technology Achieved a 27% year-over-year sales increase for VIVID products Torbal Division sales up 15% year-over-year DOTS MPS...